Skip to content
healthcare.dev

OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE

NDC 16729-367, OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, tablet, film coated, from Accord Healthcare Inc..

Product NDC
16729-367
Status
Listed
Labeler
Accord Healthcare Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209281
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16729-367 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLMESARTAN MEDOXOMIL40 mg/1
  • HYDROCHLOROTHIAZIDE12.5 mg/1

Pharmacologic classes

Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
16729-367-151672903671590 TABLET, FILM COATED in 1 BOTTLE (16729-367-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d858a6de-dda5-4bcd-a255-5723d01d896f

Use it

Look up 16729-367 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16729-367 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16729-367. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.